Medicine and Dentistry
Prostate Cancer
100%
Positron Emission Tomography-Computed Tomography
41%
Fluorine-18
22%
Lymph Node
21%
Prospective Study
18%
Biological Marker
18%
Quality of Life
15%
Bone Metastasis
14%
Randomized Controlled Trial
14%
Malignant Neoplasm
12%
Lymph Node Metastasis
12%
Bone Scintigraphy
9%
Castration Resistant Prostate Cancer
9%
Biopsy Technique
8%
Pelvis
7%
Disease
7%
Enzalutamide
7%
Abiraterone Acetate
7%
Positron Emission Tomography
7%
Systematic Review
7%
Prednisone
7%
Prostate Specific Antigen
6%
Choline
6%
Prostatectomy
6%
Gleason Score
5%
Cancer Specific Survival
5%
Metastatic Carcinoma
5%
Computer Assisted Tomography
5%
Magnetic Resonance Imaging
5%
Radiation Therapy
5%
Retroperitoneal Lymph Node Dissection
5%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
76%
Biological Marker
20%
Malignant Neoplasm
12%
Prospective Study
11%
Castration Resistant Prostate Cancer
10%
Polyethylene Terephthalate
8%
Prevalence
8%
Fluorine 18
8%
Prostate Specific Antigen
8%
Androgen
8%
Observational Study
7%
Enzalutamide
7%
Abiraterone Acetate
7%
Prednisone
7%
Gleason Score
7%
Disease
6%
Bone Metastasis
6%
